Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / Oxford Bioscience Partners (adjunct) II L.P.

Oxford Bioscience Partners (adjunct) II L.P.

Wound downUnknownFundADV: Venture Capital FundOxford Bioscience III CorporationDelaware
Amounts, each with its basis
Vintage
unknownno dated first sale or first report yet
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknown
First sale
unknown
Reported GAV
$1.1Mon the Form ADV filed Mar 24, 2015; the fund's assets, never its size or dry powder
Owners (ADV)
2
Reported on ADV
Mar 30, 2012 to Mar 24, 2015no longer reported: wound down, transferred or renamed
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Wound down
dropped from Form ADV while the adviser kept filing
last reported: n/a
The fund's own reporting through time
7 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2012Venture Capital Fund$2.5M
2$500,0001%no
Jun 26, 2012Venture Capital Fund$2.5M
2$500,0001%no
Jul 26, 2012Venture Capital Fund$2.5M
2$500,0001%no
Mar 27, 2013Venture Capital Fund$1.1M
2$500,0001%no
Nov 1, 2013Venture Capital Fund$1.1M
2$500,0001%no
Mar 28, 2014Venture Capital Fund$1.1M
2$500,0001%no
Mar 24, 2015Venture Capital Fund$1.1M
2$500,0001%no
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Mar 3, 2016
    Oxford Bioscience Partners (adjunct) II L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
  2. Mar 30, 2012
    Oxford Bioscience Partners (adjunct) II L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $2,495,672
Evidence
0 observations
Every observation on this vehicle